Idexx Laboratories | IDXX - Sales Revenues


Idexx Laboratories reported $1.22B in Sales Revenues for its fiscal quarter ending in June of 2026.





Sales Change Date
Abbott USD 12.59B 1.43B Jun/2026
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.06B 20M Jun/2026
AngioDynamics USD 79.43M 3.72M Sep/2025
Dentsply International USD 898M 18M Jun/2026
Dexcom USD 1.31B 120M Jun/2026
Edwards Lifesciences USD 1.74B 90M Jun/2026
Fujifilm JPY 826.49B 100.76B Jun/2026
Globus Medical USD 789.61M 29.76M Jun/2026
Henry Schein USD 3.46B 90M Jun/2026
Idexx Laboratories USD 1.22B 80M Jun/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 801.7M 40M Jun/2026
Integra LifeSciences USD 418.8M 26.9M Jun/2026
Intuitive Surgical USD 2.89B 120M Jun/2026
Neogen USD 225.3M 14.1M Mar/2026
Orthofix International USD 219.91M 14.28M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
ResMed USD 1.46B 60M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Steris USD 1.5B 90M Jun/2026
Tandem Diabetes Care USD 254.6M 7.38M Jun/2026
Teleflex USD 570.3M 22M Jun/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Zoetis USD 2.5B 200M Jun/2026